AC2993 (synthetic exendin-4)Patient Focus
PLUS Single
Insulin Injection
Type 2 Diabetes
Beta-cellfunction
Disease Progression
PLUS Multiple Insulin Injections
DietExercise
Normal
Absent
PLUS
Oral agents
CLINICALSTUDIES
Previous slide
Next slide
Back to first slide
View graphic version